Polyethylene Glycol-Coated (Pegylated) Liposomal Doxorubicin Rationale for Use in Solid Tumours
作者： A. Gabizon , F. Martin
DOI: 10.2165/00003495-199700544-00005
关键词: PEG ratio 、 Pharmacology 、 Dosage form 、 Drug 、 Liposome 、 Medicine 、 Doxorubicin 、 Drug carrier 、 Polyethylene glycol 、 Pharmacokinetics
摘要: Polyethylene glycol (PEG)-coated (pegylated; Stealth®) liposomes are stable, long-circulating drug carriers useful for delivering doxorubicin to the sites of solid tumours. Compared with …
springer.com
sci-hub.se 参考文章(27)
A D Dayan, Pharmacological-toxicological expert report. CAELYX. (Stealth liposomal doxorubicin HCl). Human & Experimental Toxicology. ,vol. 15, pp. 751- 785 ,(1996)
Thomas R. Alosco, Richard B. Bankert, Eric Mayhew, Frank J. Martin, Scott S. Williams, Danilo D. Lasic, Arrest of human lung tumor xenograft growth in severe combined immunodeficient mice using doxorubicin encapsulated in sterically stabilized liposomes. Cancer Research. ,vol. 53, pp. 3964- 3967 ,(1993)
W. R. Greco, Y. Tung, D. E. Brenner, R. Ginsberg, P. J. Creaven, N. Petrelli, F. Pilkiewicz, M. Ostro, J. W. Cowens, Initial Clinical (Phase I) Trial of TLC D-99 (Doxorubicin Encapsulated in Liposomes) Cancer Research. ,vol. 53, pp. 2796- 2802 ,(1993)
Beatrice Uziely, Yechezkel Barenholz, Raphael Catane, Tamar Safra, Alberto Gabizon, Francis Martin, Rivka Cohen, Anthony Huang, Bela Kaufman, Prolonged Circulation Time and Enhanced Accumulation in Malignant Exudates of Doxorubicin Encapsulated in Polyethylene-glycol Coated Liposomes Cancer Research. ,vol. 54, pp. 987- 992 ,(1994)
Katsuyuki Kunieda, Richard B. Bankert, Hisashi Kida, Fang-An Chen, F. J. Martin, Takashi Sakakibara, Rosa E. Cuenca, Doxorubicin Encapsulated in Sterically Stabilized Liposomes Is Superior to Free Drug or Drug-containing Conventional Liposomes at Suppressing Growth and Metastases of Human Lung Tumor Xenografts Cancer Research. ,vol. 56, pp. 3743- 3746 ,(1996)
Alberto A. Gabizon, Yechezkel Barenholz, Meir Bialer, Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs. Pharmaceutical Research. ,vol. 10, pp. 703- 708 ,(1993) , 10.1023/A:1018907715905
Demetrios Papahadjopoulos, Eric Mayhew, Shi Kun Huang, Frank J. Martin, Syed Gilani, Danilo D. Lasic, Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Research. ,vol. 52, pp. 6774- 6781 ,(1992)
S Unezaki, Enhanced tumor targeting and improved antitumor activity of doxorubicin by long-circulating liposomes containing amphipathic poly(ethylene glycol) International Journal of Pharmaceutics. ,vol. 126, pp. 41- 48 ,(1995) , 10.1016/0378-5173(95)04074-9
Donald W. Northfelt, Francis J. Martin, Peter Working, Paul A. Volberding, Julie Russell, Mary Newman, Michael A. Amantea, Lawrence D. Kaplan, Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma The Journal of Clinical Pharmacology. ,vol. 36, pp. 55- 63 ,(1996) , 10.1002/J.1552-4604.1996.TB04152.X
Jan Vaage, Emilio Barberá-Guillem, Robert Abra, Anthony Huang, Peter Working, Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts. Cancer. ,vol. 73, pp. 1478- 1484 ,(1994) , 10.1002/1097-0142(19940301)73:5<1478::AID-CNCR2820730526>3.0.CO;2-1